AC
Applied Clinical Trials
ACT Brief: RBQM Analysis Frequency, Building Trust in Oncology Data, and Rare Pediatric PRV Monetization
0:00-1:50
In today's ACT Brief, we examine proportionate analysis frequency in RBQM, how to build trust into real-world evidence foundations for cancer trials, and how rare disease developers monetize regulatory success.
Publisher
Applied Clinical Trials
Link
audioboom.com/posts/8962192
Published
October 9, 2026
Duration
2 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
AC
Applied Clinical Trials
@appliedclinicaltrials
#rbqmanalysisfrequency #buildingtrust #rarepediatricprv #lifesciences
